APA (7th ed.) Citation

Stergiou, C., Williams, R., Fleming, J. R., Zouvelou, V., Ninou, E., Andreetta, F., . . . Tzartos, S. (2023). Immunological and structural characterization of titin main immunogenic region: I110 domain is the target of titin antibodies in myasthenia gravis. Biomedicines, 11(2), . https://doi.org/10.3390/biomedicines11020449

Chicago Style (17th ed.) Citation

Stergiou, Christos, et al. "Immunological and Structural Characterization of Titin Main Immunogenic Region: I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis." Biomedicines 11, no. 2 (2023). https://doi.org/10.3390/biomedicines11020449.

MLA (9th ed.) Citation

Stergiou, Christos, et al. "Immunological and Structural Characterization of Titin Main Immunogenic Region: I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis." Biomedicines, vol. 11, no. 2, 2023, https://doi.org/10.3390/biomedicines11020449.